3D Systems Corp
DDD1.600USD
-0.030-1.84%
Cierre 08/01, 16:00（ET）Cotizaciones retrasadas 15 min
216.58MCap. mercado
PérdidaP/E TTM
Más Datos de 3D Systems Corp Compañía
3D Systems Corporation provides comprehensive three-dimensional (3D) printing and digital manufacturing solutions, including 3D printers for plastics and metals, materials, software, and services, including maintenance, advanced manufacturing and applications engineering. The Company’s segments include Healthcare Solutions and Industrial Solutions. The Healthcare Solutions segment serves industry verticals, including dental, medical devices, personalized health services and regenerative medicine. The Industrial Solutions segment serves industry verticals, including aerospace, defense, transportation and general manufacturing. The Company architects solutions specific to customers’ needs through a combination of materials, hardware platforms, software, professional services and advanced manufacturing. It markets its products and services through subsidiaries in North America and South America, Europe and the Middle East and Asia Pacific and Oceania.
Información de la empresa
Símbolo de cotizaciónDDD
Nombre de la empresa3D Systems Corp
Fecha de salida a bolsaMar 26, 2011
Fundada en1993
Director ejecutivoDr. Jeffrey A. (Jeff) Graves, Ph.D.
Número de empleados1833
Tipo de seguridadOrdinary Share
Fin del año fiscalMar 26
Dirección333 Three D Systems Cir
CiudadROCK HILL
Bolsa de valoresNYSE Consolidated
PaísUnited States of America
Código postal29730
Teléfono18033263900
Sitio Webhttps://www.3dsystems.com/
Símbolo de cotizaciónDDD
Fecha de salida a bolsaMar 26, 2011
Fundada en1993
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
597.98K
+4.99%
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
447.58K
+24.65%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
+11.98%
Mr. Jeffrey D. Creech
Mr. Jeffrey D. Creech
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
242.54K
+44.77%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
+19.17%
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
+24.61%
Ms. Malissia R. Clinton
Ms. Malissia R. Clinton
Independent Director
Independent Director
--
--
Mr. Charles G. (Chip) Mcclure, Jr.
Mr. Charles G. (Chip) Mcclure, Jr.
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Joseph (Joe) Zuiker
Mr. Joseph (Joe) Zuiker
Executive Vice President - Engineering and Operations
Executive Vice President - Engineering and Operations
--
--
Mr. Jimmy D. (Jim) Kever, J.D.
Mr. Jimmy D. (Jim) Kever, J.D.
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Charles W. Hull
Dr. Charles W. Hull
Executive Vice President, Chief Technology Officer - Regenerative Medicine
Executive Vice President, Chief Technology Officer - Regenerative Medicine
597.98K
+4.99%
Mr. Reji Puthenveetil
Mr. Reji Puthenveetil
Executive Vice President - Additive Solutions, Chief Commercial Officer
Executive Vice President - Additive Solutions, Chief Commercial Officer
447.58K
+24.65%
Mr. Kevin S. Moore
Mr. Kevin S. Moore
Independent Director
Independent Director
271.70K
+11.98%
Mr. Jeffrey D. Creech
Mr. Jeffrey D. Creech
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
Chief Financial Officer, Executive Vice President, Principal Accounting Officer
242.54K
+44.77%
Dr. John J. Tracy
Dr. John J. Tracy
Independent Director
Independent Director
180.71K
+19.17%
Dr. Vasant Padmanabhan
Dr. Vasant Padmanabhan
Independent Director
Independent Director
147.18K
+24.61%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
Products
54.72M
57.88%
Services
39.82M
42.12%
Sin datos
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Products
54.72M
57.88%
Services
39.82M
42.12%
Estadísticas de accionistas
Actualizado: vie., 16 de may
Actualizado: vie., 16 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.60%
The Vanguard Group, Inc.
5.35%
State Street Global Advisors (US)
4.37%
Geode Capital Management, L.L.C.
2.24%
Two Sigma Investments, LP
1.98%
Other
79.45%
Accionistas
Accionistas
Proporción
BlackRock Institutional Trust Company, N.A.
6.60%
The Vanguard Group, Inc.
5.35%
State Street Global Advisors (US)
4.37%
Geode Capital Management, L.L.C.
2.24%
Two Sigma Investments, LP
1.98%
Other
79.45%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
23.78%
Investment Advisor/Hedge Fund
14.59%
Hedge Fund
6.03%
Research Firm
4.47%
Individual Investor
3.82%
Family Office
1.05%
Bank and Trust
0.19%
Pension Fund
0.09%
Insurance Company
0.02%
Other
45.95%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
569
68.62M
50.30%
-21.59M
2025Q1
587
72.49M
53.18%
-18.98M
2024Q4
592
79.50M
58.62%
-5.75M
2024Q3
589
77.38M
57.87%
-20.75M
2024Q2
584
90.33M
67.61%
-8.75M
2024Q1
591
91.23M
68.27%
-11.77M
2023Q4
599
91.77M
68.70%
-8.99M
2023Q3
605
90.63M
67.88%
-16.10M
2023Q2
615
94.67M
72.15%
-10.52M
2023Q1
640
92.61M
71.04%
-9.20M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
BlackRock Institutional Trust Company, N.A.
9.01M
6.6%
+93.54K
+1.05%
Mar 31, 2025
The Vanguard Group, Inc.
7.30M
5.35%
+193.56K
+2.72%
Mar 31, 2025
State Street Global Advisors (US)
5.97M
4.37%
+2.04K
+0.03%
Mar 31, 2025
Geode Capital Management, L.L.C.
3.06M
2.24%
+74.90K
+2.51%
Mar 31, 2025
Two Sigma Investments, LP
2.70M
1.98%
-226.90K
-7.75%
Mar 31, 2025
ICON Advisers, Inc.
2.10M
1.54%
+500.00K
+31.25%
Mar 31, 2025
Silverberg Bernstein Capital Management, LLC
1.53M
1.12%
+210.81K
+15.93%
Mar 31, 2025
Dimensional Fund Advisors, L.P.
1.72M
1.26%
+388.23K
+29.19%
Mar 31, 2025
Nuveen LLC
1.65M
1.21%
+1.32M
+402.38%
Mar 31, 2025
Millennium Management LLC
1.62M
1.19%
-1.97M
-54.82%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: hace 6 horas
Actualizado: hace 6 horas
Nombre
Proporción
Pacer BlueStar Engineering the Future ETF
5.7%
ProShares S&P Kensho Smart Factories ETF
3.7%
3D Printing ETF
2.92%
SPDR S&P Kensho New Economies Composite ETF
0.48%
Gabelli Automation ETF
0.36%
Inspire Small/Mid Cap ESG ETF
0.14%
iShares Micro-Cap ETF
0.05%
Invesco RAFI US 1500 Small-Mid ETF
0.02%
Vanguard US Value Factor ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Ver más
Pacer BlueStar Engineering the Future ETF
Proporción5.7%
ProShares S&P Kensho Smart Factories ETF
Proporción3.7%
3D Printing ETF
Proporción2.92%
SPDR S&P Kensho New Economies Composite ETF
Proporción0.48%
Gabelli Automation ETF
Proporción0.36%
Inspire Small/Mid Cap ESG ETF
Proporción0.14%
iShares Micro-Cap ETF
Proporción0.05%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.02%
Vanguard US Value Factor ETF
Proporción0.02%
ProShares UltraPro Russell2000
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
